Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide.
The price target for Scales has been updated to NZ$6.90 from NZ$6.85, a small move that still matters if you are tracking valuation closely. Analysts who are more positive on the stock link this NZ$0.05 uplift to refreshed fair value work and a view that the company's earnings power can support the revised target. Read on to see how this evolving narrative might shape the way you assess Scales from here.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
Seaport Research continues to focus on Scales in its broader chemicals coverage. This signals the stock remains on the radar of sector specialists who are actively updating their work ahead of earnings seasons.
-
The recent commentary from Seaport around rating adjustments for chemical names highlights an interest in earnings power and capital discipline. These themes are often key inputs into how analysts frame fair value and refine price targets, such as the recent move to NZ$6.90.
🐻 Bearish Takeaways
-
The same Seaport Research pieces that reference Scales also emphasize rating changes across the chemicals space. This can remind investors that sentiment and valuation multiples may shift quickly as new earnings information comes through.
-
With limited, detailed company specific research disclosed in the available material, there is still uncertainty for you around how consistently Scales can execute against analyst expectations, particularly when sector peers are also under review.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 3 risks for Scales. See which could impact your investment.
How This Changes the Fair Value For Scales
-
Fair value updated to NZ$6.90 from NZ$6.85, representing a very small uplift in the modelled valuation level.
-
Revenue growth assumption set at 15.65% compared with 15.88% previously.
-
Net profit margin assumption now 5.72% versus 6.74% previously.
-
Future P/E multiple set at 16.27x compared with 12.90x earlier.
-
Discount rate held steady at 7.274% with no change in the assumed risk setting.
Never Miss an Update: Follow The Narrative
Narratives link a company's business story to a financial forecast and an implied fair value, so you can see why certain assumptions sit behind a price target. They refresh as new information comes through, giving you a structured way to track how the thesis is evolving.
Head over to the Simply Wall St Community and follow the Narrative on Scales to stay up to date on:
-
How a greater focus on premium apple varieties, now around 75% of volumes, ties into revenue per unit and earnings resilience.
-
The role of the Global Proteins and Logistics segments in reducing reliance on New Zealand horticulture and smoothing overall earnings.
-
Key risks such as weather and climate exposure, rising international competition, and higher regulatory and input cost pressures that could challenge margins.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SCL.NZ .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
